TUSTIN, Calif., Aug. 14 /PRNewswire-FirstCall/ --- AMDL Inc. (NYSE Alternext US: ADL), a U.S.-based pharmaceutical company with major operations in China, announced today it has filed a Notification of Late Filing under Rule 12b-25 of the Securities Exchange Act of 1934, as amended, with the Securities and Exchange Commission (the "SEC") for its Quarterly Report on Form 10-Q for the second quarter ended June 30, 2009. This filing provides for an extension for the filing of its Quarterly Report on Form 10-Q until August 19, 2009.
The Company's Quarterly Report on Form 10-Q for the six months ended June 30, 2009, could not be filed within the prescribed period because the Company was unable to compile certain information required in order to permit the Company to file a timely and accurate report on the Company's financial condition. This inability could not have been eliminated by the Company without unreasonable effort or expense. We expect to file the Quarterly Report within the allotted time.
The Company also expects to hold its Annual General Meeting of Shareholders on the originally scheduled date of Friday, August 21, 2009 at 10:30am PDT at its corporate office, which is located at 2492 Walnut Avenue, Suite 100, Tustin, California 92780. For additional information contact AMDL Investor Relations at 206.310.5323 or kszarkowitz@amdl.com.
About AMDL:
Headquartered in Tustin, CA with operations in China, AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc. (JPI), is a pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. The Company employs over 510 people in the U.S. and China.
Forward Looking Statements:
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company's operations, markets, services, products, and prices. With respect to AMDL Inc., except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements.
AMDL Contact:
Kristine Szarkowitz
Director-Investor Relations
kszarkowitz@amdl.com
(Tel :) 206.310.5323
SOURCE AMDL Inc.
